Eli Lilly & Co. (LLY) to Charge $2,100 Per Dose of Bebtelovimab Antibody Drug - WSJ
Lilly (NYSE: LLY) to Charge List Price of $2,100 Per Dose of Bebtelovimab Antibody Drug -- WSJ
- to Start Commercial Distribution of Covid-19 Antibody Treatment Week of Aug. 15
